Comparison of Daily Home Hemodialysis (HD) With Conventional in Center HD in Terms of Patients Quality of Life and Clinical Outcomes
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- End Stage Renal Disease
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: this is an interventional, pragmatic study with minimal risks, exposed / unexposed, prospective, longitudinal, multicentric and national conducted in metropolitan FranceMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Primary objective : The main objective of this study is to evaluate the physical activity in the daily life of patients in daily hemodialysis in comparison with patients treated 3 times a week (conventional hemodialysis) others objectives are also: To describe the characteristics of daily hemodialys...
Primary objective : The main objective of this study is to evaluate the physical activity in the daily life of patients in daily hemodialysis in comparison with patients treated 3 times a week (conventional hemodialysis) others objectives are also: To describe the characteristics of daily hemodialysis patients; To describe the prescription procedures of the home daily HD; To compare the evolution of the blood pressure between the 2 modalities of hemodialysis; To compare the frequency of hospitalizations, duration and hospitalization reasons between the 2 hemodialysis modalities; To compare the quality of life of the patients between the 2 modalities ; To evaluate the quality of the sleep of the patients between the 2 modalities ; Compare the percentage of patients with restless leg syndrome (RLS) and the severity of RLS between the two modalities; Compare the evolution of drug intake between the two modalities; Evaluate the number of abandoning subjects and causes of discontinuation of HQD;
Tracking Information
- NCT #
- NCT03737578
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Natalia Target, MD Centre Hospitalier La Roche sur Yon - France Study Chair: Cécile Courivaud, MD CHRU Jean Minjoz, Besançon, France Study Chair: Pierre Antoine Michel, MD Hôpital Tenon APHP, Paris, France
Get Well Soon